Skip to Main Content

Author Details

Daniel N Streblow
Vaccine and Gene Therapy Institute, Oregon Health and Science University
1994
117
41
PMIDPaper TitleJournal TitlePublished Year
36913428Infection with chikungunya virus confers heterotypic cross-neutralizing antibodies and memory B-cells against other arthritogenic alphaviruses predominantly through the B domain of the E2 glycoprotein.PLoS Negl Trop Dis2023
37782657Proximity-dependent mapping of the HCMV US28 interactome identifies RhoGEF signaling as a requirement for efficient viral reactivation.PLoS Pathog2023
37983245Mayaro virus pathogenesis and immunity in rhesus macaques.PLoS Negl Trop Dis2023
37643006Isolation and genome sequencing of cytomegaloviruses from Natal multimammate mice (<i>Mastomys natalensis</i>).J Gen Virol2023
37923717Aerosol delivery of SARS-CoV-2 human monoclonal antibodies in macaques limits viral replication and lung pathology.Nat Commun2023
37398229The pentameric complex is not required for vertical transmission of cytomegalovirus in seronegative pregnant rhesus macaques.bioRxiv2023
31974761Small Molecule Inhibitors Targeting Chikungunya Virus.Curr Top Microbiol Immunol2022
37552730Community-Based SARS-CoV-2 Testing Using Saliva or Nasopharyngeal Swabs to Compare the Performance of Weekly COVID-19 Screening to Wastewater SARS-CoV-2 Signals.ACS ES T Water2022
35788221Development of a next-generation chikungunya virus vaccine based on the HydroVax platform.PLoS Pathog2022
35339583Therapeutic and prophylactic treatment with a virus-specific antibody is highly effective in rodent models of Chikungunya infection and disease.Antiviral Res2022
33177198CD34<sup>+</sup> Hematopoietic Progenitor Cell Subsets Exhibit Differential Ability To Maintain Human Cytomegalovirus Latency and Persistence.J Virol2021
33601113Rat and human cytomegalovirus ORF116 encodes a virion envelope glycoprotein required for infectivity.Virology2021
33793555Non-replicating adenovirus based Mayaro virus vaccine elicits protective immune responses and cross protects against other alphaviruses.PLoS Negl Trop Dis2021
33766849Cytomegaloviral determinants of CD8[+] T cell programming and RhCMV/SIV vaccine efficacy.Sci Immunol2021
33482665Pyrimidone inhibitors targeting Chikungunya Virus nsP3 macrodomain by fragment-based drug design.PLoS One2021
33835811Targeting Chikungunya Virus Replication by Benzoannulene Inhibitors.J Med Chem2021
33723513Establishment of Monoclonal Antibody Standards for Quantitative Serological Diagnosis of SARS-CoV-2 in Low-Incidence Settings.Open Forum Infect Dis2021
33555589Antibody-Independent Quantification of Cytomegalovirus Virion Protein Incorporation Using HiBiT.Methods Mol Biol2021
34431689Comparison of SARS-CoV-2 PCR-Based Detection Using Saliva or Nasopharyngeal Swab Specimens in Asymptomatic Populations.Microbiol Spectr2021
34696518Nonhuman Primate Models of Zika Virus Infection and Disease during Pregnancy.Viruses2021
34152810Identification of Quinolinones as Antivirals against Venezuelan Equine Encephalitis Virus.Antimicrob Agents Chemother2021
34025614Human Cytomegalovirus Host Interactions: EGFR and Host Cell Signaling Is a Point of Convergence Between Viral Infection and Functional Changes in Infected Cells.Front Microbiol2021
33405337Blocking the IL-1 receptor reduces cardiac transplant ischemia and reperfusion injury and mitigates CMV-accelerated chronic rejection.Am J Transplant2021
33205500Macrophage depletion of CMV latently infected donor hearts ameliorates recipient accelerated chronic rejection.Transpl Infect Dis2021
31616920Zika Virus Causes Acute and Chronic Prostatitis in Mice and Macaques.J Infect Dis2020
31935257A neonatal nonhuman primate model of gestational Zika virus infection with evidence of microencephaly, seizures and cardiomyopathy.PLoS One2020
33228102Rat Cytomegalovirus Virion-Associated Proteins R131 and R129 Are Necessary for Infection of Macrophages and Dendritic Cells.Pathogens2020
32850474The Differentiation of Human Cytomegalovirus Infected-Monocytes Is Required for Viral Replication.Front Cell Infect Microbiol2020
32268565Human Cytomegalovirus Infection Suppresses CD34<sup>+</sup> Progenitor Cell Engraftment in Humanized Mice.Microorganisms2020
32367369Isolation and Detection of Zika Virus-Infected Rhesus Macaques Lymph Node Cells and Splenocytes.Methods Mol Biol2020
30755509Human Cytomegalovirus Immediate Early 86-kDa Protein Blocks Transcription and Induces Degradation of the Immature Interleukin-1β Protein during Virion-Mediated Activation of the AIM2 Inflammasome.mBio2019
31736977Vaccine-Induced Skewing of T Cell Responses Protects Against Chikungunya Virus Disease.Front Immunol2019
31848362Characterization of a live-attenuated HCMV-based vaccine platform.Sci Rep2019
31413072Risk of Zika microcephaly correlates with features of maternal antibodies.J Exp Med2019
31431555Human Cytomegalovirus US28 Ligand Binding Activity Is Required for Latency in CD34[+] Hematopoietic Progenitor Cells and Humanized NSG Mice.mBio2019
31316006Enhancing safety of cytomegalovirus-based vaccine vectors by engaging host intrinsic immunity.Sci Transl Med2019
31257853Studies on Dibenzylamines as Inhibitors of Venezuelan Equine Encephalitis Virus.ACS Infect Dis2019
30917980Src Family Kinase Inhibitors Block Translation of Alphavirus Subgenomic mRNAs.Antimicrob Agents Chemother2019
30733288HCMV trimer- and pentamer-specific antibodies synergize for virus neutralization but do not correlate with congenital transmission.Proc Natl Acad Sci U S A2019
29263267Emerging Alphaviruses Are Sensitive to Cellular States Induced by a Novel Small-Molecule Agonist of the STING Pathway.J Virol2018
29967348Miscarriage and stillbirth following maternal Zika virus infection in nonhuman primates.Nat Med2018
29559892<i>In Utero</i> Administration of Drugs Targeting Microglia Improves the Neurodevelopmental Outcome Following Cytomegalovirus Infection of the Rat Fetal Brain.Front Cell Neurosci2018
29343712Zika virus infection in pregnant rhesus macaques causes placental dysfunction and immunopathology.Nat Commun2018
28628616Therapeutic administration of a recombinant human monoclonal antibody reduces the severity of chikungunya virus disease in rhesus macaques.PLoS Negl Trop Dis2017
28278237Zika Virus infection of rhesus macaques leads to viral persistence in multiple tissues.PLoS Pathog2017
28380070Correction: Zika Virus infection of rhesus macaques leads to viral persistence in multiple tissues.PLoS Pathog2017
28428537Human Cytomegalovirus Induces Cellular and Humoral Virus-specific Immune Responses in Humanized BLT Mice.Sci Rep2017
28465426A Novel Agonist of the TRIF Pathway Induces a Cellular State Refractory to Replication of Zika, Chikungunya, and Dengue Viruses.mBio2017
26933055Complex Interplay of the UL136 Isoforms Balances Cytomegalovirus Replication and Latency.mBio2016
27736984Dysregulated TGF-β Production Underlies the Age-Related Vulnerability to Chikungunya Virus.PLoS Pathog2016
  • 1 - 50 of 117

Recommended Authors

David Sachs
Icahn School of Medicine at Mount Sinai
Career Start Year 2013
Number of shared co-authors 0
Mary K McCarthy
University of Colorado School of Medicine
Career Start Year 2012
Number of shared co-authors 5
Craig B Wilen
Yale School of Medicine
Career Start Year 2010
Number of shared co-authors 3
Thomas J Gardner
Icahn School of Medicine at Mount Sinai
Career Start Year 2009
Number of shared co-authors 1
Jason A Wojcechowskyj
Gladstone Institutes
Career Start Year 2007
Number of shared co-authors 1
Stephanie A Montgomery
and Lineberger Comprehensive Cancer Center, University of North Carolina System
Career Start Year 2006
Number of shared co-authors 4
Cherie T Ng
The Scripps Research Institute
Career Start Year 2004
Number of shared co-authors 0
Claudia T Flynn
The Scripps Research Institute
Career Start Year 2004
Number of shared co-authors 0
Rebecca S LaRue
Minnesota Supercomputing Institute, University of Minnesota
Career Start Year 2003
Number of shared co-authors 0
Travis R Taylor
University of Toledo
Career Start Year 2002
Number of shared co-authors 1
Lauren M Hook
Perelman School of Medicine, University of Pennsylvania
Career Start Year 2000
Number of shared co-authors 10
Jeremy P Kamil
Louisiana State University Health Sciences Center Shreveport
Career Start Year 2000
Number of shared co-authors 8
Edward P Browne
University of North Carolina at Chapel Hill
Career Start Year 2000
Number of shared co-authors 0
Jean K Lim
Icahn School of Medicine at Mount Sinai
Career Start Year 1998
Number of shared co-authors 2
Sonja M Best
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1998
Number of shared co-authors 3
Larissa B Thackray
Washington University School of Medicine
Career Start Year 1996
Number of shared co-authors 8
J??rgen Haas
University of Edinburgh
Career Start Year 1996
Number of shared co-authors 1
Benhur Lee
Icahn School of Medicine at Mount Sinai
Career Start Year 1995
Number of shared co-authors 9
Shelly J Robertson
National Institute of Allergy and Infectious Diseases
Career Start Year 1995
Number of shared co-authors 1
Laurent Coscoy
University of California Berkeley
Career Start Year 1993
Number of shared co-authors 1
Domenico Tortorella
Icahn School of Medicine at Mount Sinai
Career Start Year 1993
Number of shared co-authors 1
Ren Sun
University of California los angeles
Career Start Year 1992
Number of shared co-authors 1
Keith R Jerome
Fred Hutchinson Cancer Center
Career Start Year 1991
Number of shared co-authors 3
P Robert Beatty
School of Public Health, University of California berkeley
Career Start Year 1990
Number of shared co-authors 1
Akiko Iwasaki
Yale University
Career Start Year 1990
Number of shared co-authors 4
Peter Ghazal
UK System Immunity Research Institute, Cardiff University
Career Start Year 1985
Number of shared co-authors 2
Wendy Maury
Carver College of Medicine, University of Iowa
Career Start Year 1978
Number of shared co-authors 0
Robert F Garry
Tulane University School of Medicine
Career Start Year 1974
Number of shared co-authors 1
Alan C Whitmore
University of North Carolina at Chapel Hill
Career Start Year 1973
Number of shared co-authors 5
Ronald J Messer
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1972
Number of shared co-authors 0

Collaborators

Craig N Kreklywich
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Co-authored papers 45
Jay A Nelson
Oregon Health and Science University
Co-authored papers 44
Victor R DeFilippis
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Co-authored papers 25
Michael Denton
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Co-authored papers 16
Alec J Hirsch
Vaccine & Gene Therapy Institute, Oregon Health & Science University
Co-authored papers 14
Patrizia Caposio
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Co-authored papers 13
Thomas E Morrison
University of Colorado Anschutz Medical Campus
Co-authored papers 9
Jessica L Smith
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Co-authored papers 8
Lindsey B Crawford
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Co-authored papers 8
Mark T Heise
University of North Carolina at Chapel Hill.
Co-authored papers 8
Louis J Picker
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Co-authored papers 7
Meaghan H Hancock
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Co-authored papers 6
Andrew D Yurochko
Louisiana State University
Co-authored papers 6
Felicia Goodrum
University of Arizona
Co-authored papers 5
Richard D Smith
Pacific Northwest National Laboratory
Co-authored papers 4
Jinu Abraham
Oregon Health & Science University
Co-authored papers 4
Michael S Diamond
Washington University School of Medicine
Co-authored papers 4
David G Camp
Co-authored papers 3
Devorah C Goldman
Oregon Health & Science University
Co-authored papers 3
Finn Grey
The Roslin Institute, The University of Edinburgh
Co-authored papers 3
Shannon K McWeeney
Oregon Health & Science University, University of California Berkeley
Co-authored papers 3
William H Fleming
Oregon Health & Science University
Co-authored papers 3
David M Lewinsohn
Oregon Health and Science University
Co-authored papers 2
David H O'Connor
Co-authored papers 2
Christopher L Corless
Oregon Health & Science University
Co-authored papers 2
Guang Fan
Oregon Health and Science University
Co-authored papers 2
William J Britt
Heersink School of Medicine, University of Alabama at Birmingham
Co-authored papers 2
Michael Gale
Center for Innate Immunity and Immune Disease, University of Washington
Co-authored papers 2
Igor Landais
Vaccine and Gene Therapy Institute, Oregon Health and Sciences University
Co-authored papers 2
Byung Park
Oregon Health & Science University
Co-authored papers 2
Release 1.2